India's first intranasal vaccine, being developed by #BharatBiotech (@BharatBiotech) in collaboration with the Department of Biotechnology and its PSU, the Biotechnology Industry Research Assistance Council (BIRAC), on Friday got regulatory approval for Phase 2/3 trials. pic.twitter.com/55dpP1zDlE— IANS Tweets (@ians_india) August 13, 2021
(SocialLY brings you all the latest breaking news, fact checks and information from social media world, including Twitter (X), Instagram and Youtube. The above post contains publicly available embedded media, directly from the user's social media account and the views appearing in the social media post do not reflect the opinions of LatestLY.)













Quickly


